RT Book, Section A1 Joy, Melanie S. A2 Bertino, Joseph S. A2 DeVane, C. Lindsay A2 Fuhr, Uwe A2 Kashuba, Angela D. A2 Ma, Joseph D. SR Print(0) ID 56878366 T1 Chapter 17B. Genomics and the Kidney T2 Pharmacogenomics: An Introduction and Clinical Perspective YR 2013 FD 2013 PB The McGraw-Hill Companies PP New York, NY SN 978-0-07-174169-9 LK accesspharmacy.mhmedical.com/content.aspx?aid=56878366 RD 2024/03/28 AB To inform clinicians about the role of genetic variants as risk factors for kidney diseases.To assist clinicians in understanding how genomics can influence kidney disease progression.To inform clinicians about the contribution of pharmacogenomics toward patient care for kidney disorders.To provide clinicians with an understanding of how polymorphisms in drug metabolism and disposition genes can influence risks for drug-induced nephrotoxicity.